Erwin Gäbele
YOU?
Author Swipe
View article: The DNA Minor Groove Binders Trabectedin and Lurbinectedin Are Potent Antitumor Agents in Human Intrahepatic Cholangiocarcinoma
The DNA Minor Groove Binders Trabectedin and Lurbinectedin Are Potent Antitumor Agents in Human Intrahepatic Cholangiocarcinoma Open
Intrahepatic cholangiocarcinoma (iCCA) is the second most common primary liver tumor. Due to its aggressive nature and resistance to conventional treatments, there is a pressing need to develop novel and more effective therapies for this d…
View article: The DNA Minor Groove Binders Trabectedin and Lurbinectedin are Potent Antitumor Agents in Human Intrahepatic Cholangiocarcinoma
The DNA Minor Groove Binders Trabectedin and Lurbinectedin are Potent Antitumor Agents in Human Intrahepatic Cholangiocarcinoma Open
Background and Aims: Intrahepatic cholangiocarcinoma (iCCA) is the second most common type of primary liver tumor. Due to its aggressive nature and resistance to conventional treatments, there is a pressing need to develop novel and more e…
View article: Four-And-A-Half LIM-Domain Protein 2 (FHL2) Deficiency Aggravates Cholestatic Liver Injury
Four-And-A-Half LIM-Domain Protein 2 (FHL2) Deficiency Aggravates Cholestatic Liver Injury Open
Cholestasis occurs in different clinical circumstances and leads to severe hepatic disorders. The four-and-a-half LIM-domain protein 2 (FHL2) is a scaffolding protein that modulates multiple signal transduction pathways in a tissue- and ce…